Follow the Lyka Labs Limited stock price and the full insider trade history of the company, a publicly traded company based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Lyka Labs Limited has published 23 reports. Market capitalisation: €2.2bn. The latest transaction was reported on 17 April 2024 (Purchase). Among the most active insiders: Nehal N. Gandhi. The full history is openly available.
23
Insider Decl.
n/a
Thresholds
€19m
19 ops.
Buy Volume
n/a
4 ops.
Sell Volume
6Σ signal
Buys €19mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,115 of 28,856 companies
36.1
score / 100
Value
26
Quality
47
FCF yld-2.7%
Earn yld-4.6%
EV/EBITDA·
ROE·
Gross mgn61%
Net mgn-7.8%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Lyka Labs Limited is a company operating in the health and pharmaceutical sector, specializing in the development of innovative solutions. It is listed on the XBOM.